@inproceedings{inproceedings, title  = {{Abstract CT330: Adjusting for confounding effects of treatment crossover in a randomized phase 2 study of dabrafenib plus trametinib in <i>BRAF</i> V600+ metastatic melanoma}},

 publisher = {{American Association for Cancer Research (AACR)}},

 url = {{https://doi.org/10.1158/1538-7445.am2014-ct330 }},

 year = {{2014}},

 month = {{10}},

 author = {{Latimer N and Amonkar M and Stapelkamp C and Sun P}},

 doi = {{10.1158/1538-7445.am2014-ct330}},

 volume = {{74}},

 journal = {{Cancer Research}},

 issue = {{19_Supplement}},

 pages = {{CT330-CT330}},

 note = {{Accessed on 2025/10/31}}}